BGHDX Performance — Baillie Gifford Health Innovation Equities Fund, Class K
Data updated: 2025-03-10
BGHDX returned −3.70% over one year to Dec 2024. The annualised 3-year return is −16.88%. The fund trailed its Global Thematic Equity category average: $100 invested three years ago grew to $57, against $92 for the category, and to $96 over one year, against $107. Volatility over the past three years was 23.45% a year. In the 12 months to Dec 2024 the fund lost a net $9.0M, and assets reached $6.30M.
BGHDX Growth of $100
What $100 invested in Baillie Gifford Health Innovation Equities Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Thematic Equity category average over the same months.
| Period | BGHDX | Category average |
|---|---|---|
| 1 year (Jan 2024 – Dec 2024) | $96 | $107 |
| 3 years (Jan 2022 – Dec 2024) | $57 | $92 |
| Since data start (Dec 2021 – Dec 2024) | $57 | $91 |
BGHDX Trailing Returns
Total returns to Dec 2024, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | −3.70% |
| 3 years (annualised) | −16.88% |
BGHDX Annual Returns
Calendar-year total returns of Baillie Gifford Health Innovation Equities Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2024 | −3.70% |
| 2023 | −11.72% |
| 2022 | −32.44% |
| 2021 (Dec–Dec) | −0.20% |
BGHDX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | −3.4% | +1.6% | +3.2% | −7.1% | +1.1% | +2.8% | +1.0% | +2.0% | +0.8% | −3.5% | −0.2% | −1.7% |
| 2023 | +5.9% | −7.3% | +2.6% | +0.4% | −2.2% | +0.3% | +3.9% | −10.9% | −9.7% | −9.8% | +7.3% | +10.0% |
| 2022 | −20.4% | −3.4% | +2.1% | −17.2% | −2.9% | +0.8% | +8.5% | +0.7% | −8.8% | +5.7% | +5.8% | −4.7% |
| 2021 | — | — | — | — | — | — | — | — | — | — | — | −0.2% |
BGHDX Risk
Risk measures from monthly returns over Jan 2022 – Dec 2024.
- 3-year volatility (annualised): 23.45%
- 3-year Sharpe ratio: -0.91 (vs 4.5% risk-free rate)
- Best month: +9.98% (Dec 2023)
- Worst month: −20.44% (Jan 2022)
BGHDX Fund Flows
Monthly money in and out of Baillie Gifford Health Innovation Equities Fund, from SEC Form N-PORT.
- 12-month net flow: −$9.0M
- 12-month gross sales (incl. reinvestments): $1.3M
- Sales ÷ redemptions: 0.13×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Dec 2024 | $0 | $28K | −$28K |
| Nov 2024 | $0 | $205K | −$205K |
| Oct 2024 | $2K | $0 | $2K |
| Sep 2024 | $0 | $30K | −$30K |
| Aug 2024 | $0 | $96K | −$96K |
| Jul 2024 | $2K | $9.5M | −$9.5M |
| Jun 2024 | $0 | $66K | −$66K |
| May 2024 | $50K | $105K | −$55K |
| Apr 2024 | $552K | $69K | $483K |
| Mar 2024 | $269K | $10K | $259K |
| Feb 2024 | $280K | $59K | $221K |
| Jan 2024 | $166K | $140K | $26K |
BGHDX Assets Under Management
Net assets of Baillie Gifford Health Innovation Equities Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2024-12-31 | $6.30M |
| 2024-09-30 | $6.89M |
| 2024-06-28 | $15.97M |
| 2024-03-28 | $16.17M |
| 2023-12-29 | $15.42M |
| 2023-09-29 | $20.16M |
| 2023-06-30 | $23.19M |
| 2023-03-31 | $23.23M |
| 2022-12-30 | $20.92M |
| 2022-09-30 | $6.32M |
| 2022-06-30 | $6.34M |
| 2022-03-31 | $7.83M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.